TFIPS
JAZZ icon

Towarzystwo Funduszy Inwestycyjnych PZU SA’s Jazz Pharmaceuticals JAZZ Stock Holding History

Towarzystwo Funduszy Inwestycyjnych PZU SA’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-480
Closed -$81.6K – 698
2025
Q4 		$81.6K Sell
480
-635
-57% -$97.4K 0.02% 322
2025
Q3 		$147K Sell
1,115
-1,105
-50% -$133K 0.03% 215
2025
Q2 		$236K Hold
2,220
– – 0.07% 137
2025
Q1 		$276K Hold
2,220
– – 0.09% 107
2024
Q4 		$273K Hold
2,220
– – 0.09% 95
2024
Q3 		$247K Hold
2,220
– – 0.09% 103
2024
Q2 		$237K Buy
2,220
+130
+6% +$14.3K 0.09% 96
2024
Q1 		$252K Hold
2,090
– – 0.11% 85
2023
Q4 		$257K Buy
+2,090
New +$261K 0.12% 72
2021
Q3 		$240K Sell
1,845
-160
-8% -$24.2K 0.29% 46
2021
Q2 		$356K Hold
2,005
– – 0.42% 36
2021
Q1 		$330K Hold
2,005
– – 0.48% 34
2020
Q4 		$331K Buy
+2,005
New +$299K 0.34% 38

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Towarzystwo Funduszy Inwestycyjnych PZU SA's JAZZ Position: Q1 2026 in Review

Towarzystwo Funduszy Inwestycyjnych PZU SA sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2026, closing a stake of 480 shares — an estimated $81.6K sold.

Towarzystwo Funduszy Inwestycyjnych PZU SA first reported a position in JAZZ in Q4 2020 and held it in 13 quarters. The position peaked at $356K in Q2 2021. 573 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • Towarzystwo Funduszy Inwestycyjnych PZU SA reported no remaining Jazz Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Towarzystwo Funduszy Inwestycyjnych PZU SA sold 480 Jazz Pharmaceuticals shares in Q1 2026, an estimated $81.6K.
  • Towarzystwo Funduszy Inwestycyjnych PZU SA first reported a position in Jazz Pharmaceuticals in Q4 2020 and held it in 13 quarters.
  • Towarzystwo Funduszy Inwestycyjnych PZU SA's Jazz Pharmaceuticals position peaked at $356K in Q2 2021.
  • 573 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Towarzystwo Funduszy Inwestycyjnych PZU SA's 13F filing for Q1 2026, filed 15 May 2026.